(Q37918311)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

review article

1 reference

title

18F-fluorocholine for prostate cancer imaging: a systematic review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Tarik-Zine Belhocine

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

M Kovacs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

A Ward

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

M Beheshti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

I Rachinsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

16 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

45-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21844889%20AND%20SRC:MED&resulttype=core&format=json

More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Imaging prostate cancer: a multidisciplinary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Imaging of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Radionuclide and hybrid imaging of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Contemporary imaging analyses of pelvic lymph nodes in the prostate cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

NCCN task force: clinical utility of PET in a variety of tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Novel tracers and their development for the imaging of metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

In vivo 31P MRS of experimental tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Studies of human tumors by MRS: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Biokinetics of 18F-choline studied in four prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Fully automated [18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Fluorocholine PET/CT in patients with prostate cancer: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissectio

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

(18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

¹⁸F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Choline PET based dose-painting in prostate cancer--modelling of dose effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

3D-segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

The effects of muscle exercise and bed rest on [18F]methylcholine PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Tumor focality in prostate cancer: implications for focal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Pathologic basis of focal therapy for early-stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Fully automated preparation of [11C]choline and [18F]fluoromethylcholine using TracerLab synthesis modules and facilitated quality control using analytical HPLC

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35

The impact of urinary excretion of (18)F-labeled choline analogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.35